Nurgul Aytan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Nurgul Aytan has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Alpaslan Dedeoglu
Department of Veterans Affairs, VA Boston Healthcare System, Boston, MA 02130, USA
5 shared publications - Bruce G. Jenkins
Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, USA
5 shared publications - Isabel Carreras
Department of Veterans Affairs, VA Boston Healthcare System, Research and Development Service, Boston, USA
5 shared publications - Ji-Kyung Choi
Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
4 shared publications - Leah Crabtree
Department of Veterans Affairs, VA Boston Healthcare System, 150 S Huntington Av., Boston, MA 02130, USA
4 shared publications - Jan Krzysztof Blusztajn
Boston University School of Medicine
3 shared publications
Latest Publications
- 1 June 2018
- Published by Elsevier in European Journal of Pharmacology
- Vol. 828, 9-17
Protective effects of 7,8-dihydroxyflavone on neuropathological and neurochemical changes in a mouse model of Alzheimer's disease
- 1 June 2018
- Published by Elsevier in European Journal of Pharmacology
- Vol. 828, 9-17
Protective effects of 7,8-dihydroxyflavone on neuropathological and neurochemical changes in a mouse model of Alzheimer's disease
- 1 February 2018
- Published by Elsevier in Brain Research
- Vol. 1681, 34-43
Anxiety, neuroinflammation, cholinergic and GABAergic abnormalities are early markers of Gulf War illness in a mouse model of the disease
- 1 February 2018
- Published by Elsevier in Brain Research
- Vol. 1681, 34-43
Anxiety, neuroinflammation, cholinergic and GABAergic abnormalities are early markers of Gulf War illness in a mouse model of the disease
- 1 February 2018
- Published by Elsevier in Experimental Neurology
- Vol. 300, 111-120
Combined administration of resolvin E1 and lipoxin A4 resolves inflammation in a murine model of Alzheimer's disease
- 1 February 2018
- Published by Elsevier in Experimental Neurology
- Vol. 300, 111-120
Combined administration of resolvin E1 and lipoxin A4 resolves inflammation in a murine model of Alzheimer's disease
- Open Access
- 1 January 2016
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 7 (1) , 36
Effect of a hypercholesterolemia as a starting factor on spinal degeneration in rabbits and role of Vitamin E (α-tocopherol)
To identify the role of the hypercholesterolemia as a starting factor in discovertebral degeneration that ultimately causes lower back pain, and investigate the role of Vitamin E in this process. The rabbits (n = 32) were divided into two broad experimental groups: A control group, and a hypercholesterolemia group, namely cholesterol, and cholesterol plus Vitamin E groups and they were fed sequentially for 4 or 8 weeks. Serum cholesterol and Vitamin E (α-tocopherol) levels were determined; vascular tissue was prepared for histopathological analyses and vertebra was decalcified for the study. Cholesterol diet group resulted approximately 44-fold of increase plasma cholesterol levels over the 4-week control values. Additional supplementation with Vitamin E group induced a plasma cholesterol level increase of only 37-fold as compared to the control group. In the cholesterol groups, light microscope examination revealed atherosclerotic plaque in major arteries. However, in the cholesterol plus Vitamin E treatment groups, no lipid accumulation or foam cell formation was visible in the abdominal aorta and vertebral segmental artery. In histopathological examination, we found degenerative changes in the discovertebral unit in cholesterol treated groups. Hypercholesterolemia causes fat accumulation in the disc endplate and vertebral body that causes blood supply disturbances which might be a starting factor of discovertebral degeneration. This event was not reversed by the elimination of cholesterol from the diet. Vitamin E supplementation was not effective in reducing fat accumulation in vertebral bone marrow. As a result, we conclude that degeneration of the discovertebral unit is not related to atherosclerotic changes in the major blood vessels.
- 1 January 2016
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 7 (1) , 36
Open AccessEffect of a hypercholesterolemia as a starting factor on spinal degeneration in rabbits and role of Vitamin E (α-tocopherol)
To identify the role of the hypercholesterolemia as a starting factor in discovertebral degeneration that ultimately causes lower back pain, and investigate the role of Vitamin E in this process. The rabbits (n = 32) were divided into two broad experimental groups: A control group, and a hypercholesterolemia group, namely cholesterol, and cholesterol plus Vitamin E groups and they were fed sequentially for 4 or 8 weeks. Serum cholesterol and Vitamin E (α-tocopherol) levels were determined; vascular tissue was prepared for histopathological analyses and vertebra was decalcified for the study. Cholesterol diet group resulted approximately 44-fold of increase plasma cholesterol levels over the 4-week control values. Additional supplementation with Vitamin E group induced a plasma cholesterol level increase of only 37-fold as compared to the control group. In the cholesterol groups, light microscope examination revealed atherosclerotic plaque in major arteries. However, in the cholesterol plus Vitamin E treatment groups, no lipid accumulation or foam cell formation was visible in the abdominal aorta and vertebral segmental artery. In histopathological examination, we found degenerative changes in the discovertebral unit in cholesterol treated groups. Hypercholesterolemia causes fat accumulation in the disc endplate and vertebral body that causes blood supply disturbances which might be a starting factor of discovertebral degeneration. This event was not reversed by the elimination of cholesterol from the diet. Vitamin E supplementation was not effective in reducing fat accumulation in vertebral bone marrow. As a result, we conclude that degeneration of the discovertebral unit is not related to atherosclerotic changes in the major blood vessels.
- 1 December 2013
- Published by Elsevier in Experimental Neurology
- Vol. 250, 228-238
Combination therapy in a transgenic model of Alzheimer's disease
- 1 December 2013
- Published by Elsevier in Experimental Neurology
- Vol. 250, 228-238
Combination therapy in a transgenic model of Alzheimer's disease